Safety of two-dose schedule of COVID-19 adsorbed inactivated vaccine (CoronaVac; Sinovac/Butantan) and heterologous additional doses of mRNA BNT162b2 (Pfizer/BioNTech) in immunocompromised and immunocompetent individuals. - Miyaji KT; Ibrahim KY; Infante V; Moreira RM; Santos CFD; Belizário JC; Pinto MIM; Marinho AKBB; Pereira JM; Mello LS; Silva VGLD; Sato PK; et al. (Revista do Instituto de Medicina Tropical de Sao Paulo, 2025)